ZTS logo

Zoetis (ZTS) EBITDA

Annual EBITDA

$3.67 B
+$324.00 M+9.69%

31 December 2023

1-Year Change

+9.69%
ZTS annual earnings before interest, taxes, depreciation & amortization is up +9.69% year-on-year

3-Year Change

+37.41%
ZTS annual earnings before interest, taxes, depreciation & amortization is up +37.41% over the past 3 years

All-time High

$3.67 B
ZTS annual earnings before interest, taxes, depreciation & amortization is currently at an all-time high

Sector Rank

97.43%
ZTS annual earnings before interest, taxes, depreciation & amortization is higher than 97.43% of companies in Healthcare sector

Annual EBITDA Formula

Net Income + Interest + Taxes + Depreciation + Amortization
Annual Revenue$8.54 B
ZTS annual revenue is $8.54 billion
Annual Gross Profit$5.98 B
ZTS annual gross profit is $5.98 billion
Annual Net Income$2.34 B
ZTS annual net profit is $2.34 billion

ZTS EBITDA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly EBITDA

$1.05 B
+$86.00 M+8.90%

30 September 2024

1-Year Change

+16.89%
ZTS quarterly earnings before interest, taxes, depreciation & amortization is up +16.89% year-on-year

3-Year Change

+27.52%
ZTS quarterly earnings before interest, taxes, depreciation & amortization is up +27.52% over the past 3 years

All-time High

$1.05 B
ZTS quarterly earnings before interest, taxes, depreciation & amortization is currently at an all-time high

Sector Rank

97.32%
ZTS quarterly earnings before interest, taxes, depreciation & amortization is higher than 97.32% of companies in Healthcare sector
Quarterly Revenue$2.39 B
ZTS quarterly revenue is $2.39 billion
Quarterly Gross Profit$1.69 B
ZTS quarterly gross profit is $1.69 billion
Quarterly Operating Profit$920.00 M
ZTS quarterly operating income is $920.00 million
Quarterly Net Income$682.00 M
ZTS quarterly net profit is $682.00 million

ZTS Quarterly EBITDA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM EBITDA

$3.78 B
+$152.00 M+4.19%

30 September 2024

1-Year Change

+4.99%
ZTS TTM earnings before interest, taxes, depreciation & amortization is up +4.99% year-on-year

3-Year Change

+23.26%
ZTS TTM earnings before interest, taxes, depreciation & amortization is up +23.26% over the past 3 years

All-time High

$3.78 B
ZTS TTM earnings before interest, taxes, depreciation & amortization is currently at an all-time high

Sector Rank

97.4%
ZTS TTM earnings before interest, taxes, depreciation & amortization is higher than 97.4% of companies in Healthcare sector
TTM Revenue$9.15 B
ZTS TTM revenue is $9.15 billion
TTM Gross Profit$6.41 B
ZTS TTM gross profit is $6.41 billion
TTM Operating Profit$3.34 B
ZTS TTM operating income is $3.34 billion
TTM Net Income$2.43 B
ZTS TTM net profit is $2.43 billion

ZTS TTM EBITDA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ZTS EBITDA Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+9.7%+16.9%+5.0%
3 y3 years+37.4%+27.5%+23.3%
5 y5 years+66.3%+52.2%+56.9%

ZTS EBITDA High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high+37.4%at high+55.4%at high+23.3%
5 y5 yearsat high+66.3%at high+79.2%at high+56.9%
alltimeall timeat high>+9999.0%at high+1923.1%at high+2125.9%

Zoetis EBITDA History

DateAnnualQuarterlyTTM
Sept 2024
-
$1.05 B(+8.9%)
$3.78 B(+4.2%)
June 2024
-
$966.00 M(+3.8%)
$3.63 B(-2.3%)
Mar 2024
-
$931.00 M(+11.5%)
$3.72 B(+1.4%)
Dec 2023
$3.67 B(+9.7%)
$835.00 M(-7.2%)
$3.67 B(+1.7%)
Sept 2023
-
$900.00 M(-14.4%)
$3.60 B(+1.8%)
June 2023
-
$1.05 B(+19.4%)
$3.54 B(+6.3%)
Mar 2023
-
$880.00 M(+13.8%)
$3.33 B(-0.4%)
Dec 2022
$3.34 B(+5.8%)
$773.00 M(-7.4%)
$3.34 B(+3.0%)
Sept 2022
-
$835.00 M(-0.6%)
$3.25 B(+0.3%)
June 2022
-
$840.00 M(-6.0%)
$3.24 B(+1.1%)
Mar 2022
-
$894.00 M(+32.1%)
$3.20 B(+1.3%)
Dec 2021
$3.16 B(+18.4%)
$677.00 M(-17.9%)
$3.16 B(+2.9%)
Sept 2021
-
$825.00 M(+2.5%)
$3.07 B(+1.8%)
June 2021
-
$805.00 M(-5.6%)
$3.02 B(+5.4%)
Mar 2021
-
$853.00 M(+45.3%)
$2.86 B(+7.2%)
Dec 2020
$2.67 B(+9.5%)
$587.00 M(-23.8%)
$2.67 B(-0.6%)
Sept 2020
-
$770.00 M(+18.3%)
$2.68 B(+3.0%)
June 2020
-
$651.00 M(-1.4%)
$2.60 B(+1.7%)
Mar 2020
-
$660.00 M(+9.6%)
$2.56 B(+5.1%)
Dec 2019
$2.44 B(+10.5%)
$602.00 M(-12.9%)
$2.44 B(+1.0%)
Sept 2019
-
$691.00 M(+13.7%)
$2.41 B(+5.9%)
June 2019
-
$608.00 M(+13.6%)
$2.28 B(+2.8%)
Mar 2019
-
$535.00 M(-7.4%)
$2.21 B(+0.5%)
Dec 2018
$2.20 B(+13.5%)
$578.00 M(+4.0%)
$2.20 B(+1.6%)
Sept 2018
-
$556.00 M(+1.8%)
$2.17 B(+2.0%)
June 2018
-
$546.00 M(+4.2%)
$2.13 B(+5.0%)
Mar 2018
-
$524.00 M(-3.5%)
$2.03 B(+4.3%)
Dec 2017
$1.94 B
$543.00 M(+5.6%)
$1.94 B(+12.0%)
DateAnnualQuarterlyTTM
Sept 2017
-
$514.00 M(+15.5%)
$1.73 B(+4.8%)
June 2017
-
$445.00 M(+1.1%)
$1.65 B(+0.7%)
Mar 2017
-
$440.00 M(+31.3%)
$1.64 B(+0.5%)
Dec 2016
$1.63 B(+88.2%)
$335.00 M(-22.8%)
$1.63 B(+11.8%)
Sept 2016
-
$434.00 M(+0.2%)
$1.46 B(+6.3%)
June 2016
-
$433.00 M(+0.2%)
$1.38 B(+38.3%)
Mar 2016
-
$432.00 M(+166.7%)
$994.00 M(+14.5%)
Dec 2015
$868.00 M(-23.9%)
$162.00 M(-53.4%)
$868.00 M(-8.1%)
Sept 2015
-
$348.00 M(+569.2%)
$944.00 M(+3.4%)
June 2015
-
$52.00 M(-83.0%)
$913.00 M(-20.0%)
Mar 2015
-
$306.00 M(+28.6%)
$1.14 B(0.0%)
Dec 2014
$1.14 B(+12.7%)
$238.00 M(-24.9%)
$1.14 B(+2.1%)
Sept 2014
-
$317.00 M(+13.2%)
$1.12 B(+5.1%)
June 2014
-
$280.00 M(-8.5%)
$1.06 B(+0.9%)
Mar 2014
-
$306.00 M(+43.0%)
$1.05 B(+4.1%)
Dec 2013
$1.01 B(+7.5%)
$214.00 M(-18.6%)
$1.01 B(+9.5%)
Sept 2013
-
$263.00 M(-2.6%)
$924.00 M(-1.2%)
June 2013
-
$270.00 M(+1.9%)
$935.00 M(-4.5%)
Mar 2013
-
$265.00 M(+110.3%)
$979.00 M(+4.0%)
Dec 2012
$941.00 M(+48.2%)
$126.00 M(-54.0%)
$941.00 M(+3.6%)
Sept 2012
-
$274.00 M(-12.7%)
$908.00 M(+7.7%)
June 2012
-
$314.00 M(+38.3%)
$843.00 M(+21.8%)
Mar 2012
-
$227.00 M(+144.1%)
$692.00 M(+9.0%)
Dec 2011
$635.00 M(+58.8%)
$93.00 M(-55.5%)
$635.00 M(+17.2%)
Sept 2011
-
$209.00 M(+28.2%)
$542.00 M(+62.8%)
June 2011
-
$163.00 M(-4.1%)
$333.00 M(+95.9%)
Mar 2011
-
$170.00 M
$170.00 M
Dec 2010
$400.00 M(>+9900.0%)
-
-
Dec 2009
$2.00 M
-
-

FAQ

  • What is Zoetis annual earnings before interest, taxes, depreciation & amortization?
  • What is the all time high annual EBITDA for Zoetis?
  • What is Zoetis annual EBITDA year-on-year change?
  • What is Zoetis quarterly earnings before interest, taxes, depreciation & amortization?
  • What is the all time high quarterly EBITDA for Zoetis?
  • What is Zoetis quarterly EBITDA year-on-year change?
  • What is Zoetis TTM earnings before interest, taxes, depreciation & amortization?
  • What is the all time high TTM EBITDA for Zoetis?
  • What is Zoetis TTM EBITDA year-on-year change?

What is Zoetis annual earnings before interest, taxes, depreciation & amortization?

The current annual EBITDA of ZTS is $3.67 B

What is the all time high annual EBITDA for Zoetis?

Zoetis all-time high annual earnings before interest, taxes, depreciation & amortization is $3.67 B

What is Zoetis annual EBITDA year-on-year change?

Over the past year, ZTS annual earnings before interest, taxes, depreciation & amortization has changed by +$324.00 M (+9.69%)

What is Zoetis quarterly earnings before interest, taxes, depreciation & amortization?

The current quarterly EBITDA of ZTS is $1.05 B

What is the all time high quarterly EBITDA for Zoetis?

Zoetis all-time high quarterly earnings before interest, taxes, depreciation & amortization is $1.05 B

What is Zoetis quarterly EBITDA year-on-year change?

Over the past year, ZTS quarterly earnings before interest, taxes, depreciation & amortization has changed by +$152.00 M (+16.89%)

What is Zoetis TTM earnings before interest, taxes, depreciation & amortization?

The current TTM EBITDA of ZTS is $3.78 B

What is the all time high TTM EBITDA for Zoetis?

Zoetis all-time high TTM earnings before interest, taxes, depreciation & amortization is $3.78 B

What is Zoetis TTM EBITDA year-on-year change?

Over the past year, ZTS TTM earnings before interest, taxes, depreciation & amortization has changed by +$180.00 M (+4.99%)